Literature DB >> 989692

The foeto-maternal distribution of digoxin in early human pregnancy.

H Allonen, J Kanto, E Iisalo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 989692     DOI: 10.1111/j.1600-0773.1976.tb03198.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


× No keyword cloud information.
  9 in total

Review 1.  The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state.

Authors:  M D Hill; F P Abramson
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of digoxin 1980.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

3.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

Review 4.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of digoxin in infants.

Authors:  G Wettrell; K E Andersson
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 6.  Placental transfer of drugs administered to the mother.

Authors:  G M Pacifici; R Nottoli
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

Review 7.  Management of cardiac arrhythmias during pregnancy. Current concepts.

Authors:  H H Rotmensch; S Rotmensch; U Elkayam
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546

8.  Placental transfer of clenbuterol early in human pregnancy.

Authors:  O Pelkonen; R Tuimala; A Kauppila
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 9.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.